Alex Zhavoronkov, PhD
Founder and Co-CEO, Insilico Medicine
Pharma & Life SciencesProvides regular updates on the application of generative AI to chemistry and biology, clinical trial milestones, and longevity research.
Generative AI / Longevity Research / Drug Discovery
Best for: AI engineers, medicinal chemists, and biotech entrepreneurs
Andrew Hopkins, PhD
Founder and CEO, Exscientia
Pharma & Life SciencesOffers visionary leadership perspectives on automated drug design, automated chemistry, and using patient-tissue-led platforms for oncology clinical trials.
AI Drug Design / Precision Oncology / Automated Chemistry
Best for: Computational chemists and precision medicine advocates
Brad Loncar
CEO, Loncar Investments
Pharma & Life SciencesOffers real-time commentary on biotechnology stock markets, clinical trial readouts, and global pharmaceutical industry trends, including a strong focus on Chinese biotech.
Biotech Investing / Cancer Immunotherapy / Global Pharma
Best for: Public market biotech investors and industry analysts
Bruce Booth, PhD
Partner, Atlas Venture
Pharma & Life SciencesOffers detailed, data-driven analysis of biotech venture capital trends, early-stage drug development, and the financial ecosystem supporting new therapeutics.
Biotech Investing / Drug Discovery / Venture Capital
Best for: Biotech founders, venture capitalists, and life sciences executives
Craig Lipset, MPH
Founder and Advisor, Clinical Innovation Partners
Pharma & Life SciencesDelivers deep insights into the modernization of clinical trials, decentralization strategies, digital health tools, and patient advocacy integration in drug development.
Clinical Trials / Decentralized Trials / Patient Centricity
Best for: Clinical trial operations managers and digital health innovators
Daphne Koller, PhD
Founder and CEO, insitro
Pharma & Life SciencesExplores how advanced machine learning can transform drug discovery and clinical development, sharing key updates on predictive biology and therapeutic design.
Machine Learning / Drug Discovery / Computational Biology
Best for: AI researchers and computer-aided drug discovery specialists
John Maraganore, PhD
Founder and Principal, JMaraganore Consulting
Pharma & Life SciencesShares valuable executive-level mentorship, insights on biotech corporate governance, and expert perspectives on the next generation of genomic and molecular therapies.
RNA Interference / Biotech Leadership / Drug Development
Best for: Biotech executives, drug developers, and researchers
Peter Kolchinsky, PhD
Managing Partner, RA Capital Management
Pharma & Life SciencesWrites extensively on drug pricing policy, patent ecosystems, biotech capital markets, and the societal value of pharmaceutical innovation.
Biotech Policy / Drug Pricing / Venture Capital
Best for: Healthcare policy analysts, biotech executives, and investors
Thomas Clozel, MD
Co-Founder and CEO, Owkin
Pharma & Life SciencesDiscusses how federated learning and artificial intelligence can optimize clinical trials, discover new biomarkers, and advance precision oncology.
AI in Oncology / Precision Medicine / Federated Learning
Best for: Oncologists, data scientists, and pharmaceutical researchers
Showing 9 of 121 people. Listings are editorial, not paid, and nobody pays to appear here.